Copyright: ©Author(s) 2026.
World J Cardiol. Apr 26, 2026; 18(4): 116558
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.116558
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.116558
Table 1 Key downstream targets and pathological consequences of aberrant Ca2+/calmodulin-dependent protein kinase II activation in heart failure
| Specific target | CaMKII action | Pathophysiological consequence |
| RyR2 | Phosphorylates RyR2 at Ser2814, increasing its open probability | Increased sarcoplasmic reticulum calcium leak, elevated diastolic calcium spark frequency, leading to abnormal calcium transients and triggered arrhythmias |
| PLB | Phosphorylates PLB at Thr17, relieving its inhibition on SERCA2a | Initially compensatory enhanced calcium reuptake; chronic/over-activation synergizes with SERCA2a downregulation, resulting in reduced SR calcium load and diastolic dysfunction |
| LTCC | Phosphorylates LTCC at Thr1604, prolonging channel opening and slowing inactivation | Increased calcium influx, prolonged action potential duration, establishing the substrate for early afterdepolarizations; exacerbates calcium overload |
| Nav1.5 | Phosphorylates Nav1.5 at Ser516/Thr594, enhancing the late sodium current | Induces intracellular sodium overload, indirectly worsens calcium overload and action potential prolongation, significantly increasing arrhythmia risk |
| NCX | Indirectly promotes NCX protein expression via upstream signals (e.g., oxidative stress) | Increases reverse-mode NCX activity, leading to calcium influx and overload, impairing electrophysiological stability |
| Ito | Reduces Ito current density and function through chronic downregulation and acute phosphorylation-dependent gating modulation | Impairs early repolarization, prolongs action potential duration, and compromises repolarization reserve |
| HDAC | Phosphorylates and activates class I HDACs (e.g., HDAC1, HDAC3), driving pathological gene reprogramming | Promotes myocardial hypertrophy, fibrosis, and pathological remodeling |
- Citation: Zhang YF, Yang WX, Li XW. Letter to the Editor: Ca2+/calmodulin-dependent protein kinase II in heart failure and the role of sodium-glucose-cotransporter 2 inhibitors. World J Cardiol 2026; 18(4): 116558
- URL: https://www.wjgnet.com/1949-8462/full/v18/i4/116558.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i4.116558
